Literature DB >> 13489180

The ethyleneiminium ion as the active species in 2-haloalkylamine compounds.

J D GRAHAM.   

Abstract

Certain 2-haloethylamine compounds which exert antagonism to adrenaline and noradrenaline of the type shown by dibenamine have been examined. The compounds were N-ethyl-N-chlorobenzyl-2-chloroethylamine hydrochlorides in which the Cl is in the p-, o-, and m- positions of the benzene ring, and the three related ethyleneiminium picrylsulphonates. In addition the Cl- and Br- compounds of the N-ethyl-N-9-fluorenyl-2-haloethylamine hydrohalide series were examined. For the haloethylamines, a curve was provided which showed the relation between probable production and decay of ethyleneiminium ion in neutralized solution with time. A correlation was established between the shape of this curve and the curve relating anti-adrenaline and anti-noradrenaline activity of samples of solutions of these compounds treated in an identical way. The relation to antagonism of histamine and 5-hydroxytryptamine was not so exact and varied with species.The ethyleneiminium ions of the three chlorobenzyl compounds exerted a typical long-lasting non-competitive antagonism to the pressor actions of adrenaline and noradrenaline. They also antagonized the effect of 5-hydroxytryptamine and histamine on blood pressure. The ED50 of the ion when administered as ethyleneiminium picrylsulphonate was always less than the ED50 of the same ion when administered in the form of 2-haloethylamine. There was, therefore, a variable loss of effective ion during transformation in vivo. The observations throw some light on the importance of the substituent groups on the nitrogen atom for effectiveness. It is concluded from these results and a discussion of other work that 2-haloethylamine compounds form an ethyleneiminium ion in neutral solution, which is the pharmacologically active species in effective compounds. It is a necessary but not a sufficient condition that a molecule should be an alkylating agent for this type of antagonism to be present, but the importance of the substituent groups on the N atom is equally great because not all ethyleneiminium ions are effective antagonists.

Entities:  

Keywords:  AMINES

Mesh:

Substances:

Year:  1957        PMID: 13489180      PMCID: PMC1510594          DOI: 10.1111/j.1476-5381.1957.tb00171.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  3 in total

1.  The chemical transformations of dibenamine and dibenzyline and biological activity.

Authors:  S C HARVEY; M NICKERSON
Journal:  J Pharmacol Exp Ther       Date:  1953-11       Impact factor: 4.030

2.  The physiological disposition and biotransformation of dibenamine and a method for its estimation in biological tissues.

Authors:  J AXELROD; L ARONOW; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1952-10       Impact factor: 4.030

3.  Relationship between anti-adrenaline and antihistamine activity in a series of beta-haloethylamines.

Authors:  J D P GRAHAM; G P LEWIS
Journal:  J Physiol       Date:  1952-03       Impact factor: 5.182

  3 in total
  6 in total

1.  A simple method for quantifying functional selectivity and agonist bias.

Authors:  Terry Kenakin; Christian Watson; Vanessa Muniz-Medina; Arthur Christopoulos; Steven Novick
Journal:  ACS Chem Neurosci       Date:  2011-12-20       Impact factor: 4.418

2.  DISTRIBUTION OF (2-BROMOETHYL)ETHYL(NAPHTH-1-YMETHYL-(14C))AMINE HYDROBROMIDE IN THE RAT.

Authors:  J D GRAHAM
Journal:  Br J Pharmacol Chemother       Date:  1964-10

3.  Binding of N-(2-bromo ethyl)-N-ethyl-N 1 -naphthylmethylamine HBr (SY28) to the proteins of guinea-pig vas deferens.

Authors:  J D Graham; D R Mottram
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

4.  The effect of choline mustard on the rat superior cervical ganglia.

Authors:  M C Allen
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

5.  The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors.

Authors:  Richard G W Proudman; Andre S Pupo; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2020-08

6.  The affinity and selectivity of α-adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.

Authors:  Richard G W Proudman; Juliana Akinaga; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2022-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.